Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

26 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Estradiol Vaginal Tablets Articles

Novo Nordisk in deal with Upsher-Smith to market new dose Vagifem in USA

24 August 2010

Novo Nordisk enrolls Innovex for menopause drugs sales

29 March 2004

Pfizer tries to end Novo HRT deal

9 June 2003

Pretax profits up 25% at Novo Nordisk

18 February 2002

Pretax profits up 33% at Novo Nordisk

7 November 2001

Novo Nordisk optimistic about reaching 2001 earnings goal; 1st-half EPS up

7 August 2001

Pharmacia launches Vagifem in USA

3 August 2000

Novo Nordisk and AHP settle patent dispute

16 June 2000

Pharmacia gains FDA OK for Activella

18 April 2000

P&U to market Novo Nordisk's HRT drugs in USA

13 January 2000

R-PR And Novo Forge HRT Alliance

20 May 1996

UK INDUSTRY CODE OF PRACTICE REVIEW

19 July 1993

Showing 1-12 of 12 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
  • Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
  • Proposal to list Roche's Neulastim and Actemra in New Zealand
  • Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
  • Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
  • Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS